financetom
Business
financetom
/
Business
/
LL Bean agrees to injunction to end Skechers shoe lawsuit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LL Bean agrees to injunction to end Skechers shoe lawsuit
Dec 26, 2024 11:51 AM

NEW YORK (Reuters) - LL Bean, the clothing and outdoor gear company, agreed to stop selling a line of casual shoes to settle a lawsuit in which Skechers USA ( SKX ) accused it of copying a design for its own shoes, which have sold in the millions.

U.S. District Judge Margaret Garnett in Manhattan approved an injunction on Thursday that bars privately-held LL Bean from making, importing or selling shoes that infringe two Skechers design patents until the last of the patents expires.

In a complaint filed in July, Skechers claimed that LL Bean's Freeport shoes, named for that company's Maine hometown and which retailed for $99, infringed two patented designs for "heel cups" that surround the back of the foot.

The world's third-largest footwear company accused LL Bean of trying to piggyback on the success of its own unique heel cup design, which it said incorporated "graceful, sweeping, gently rolling lines and slopes" that resembled the shape of a heel.

Other settlement terms were not disclosed. Skechers had also sought unspecified damages. Its patents expire in 2038, according to the complaint.

Neither LL Bean nor its lawyers immediately responded to requests for comment. Skechers and its lawyers did not immediately respond to similar requests.

LL Bean was founded in 1912. Skechers was founded in 1992 and is based in Manhattan Beach, California.

The case is Skechers USA Inc ( SKX ) et al v LL Bean Inc, U.S. District Court, Southern District of New York, No. 24-05336.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Chime set for long-awaited market debut after $864 million US IPO
Chime set for long-awaited market debut after $864 million US IPO
Jun 12, 2025
* Chime prices IPO at $27, above proposed range * Fetches fully diluted valuation of $11.6 billion * Performance seen as bellwether for other fintech IPOs By Manya Saini and Niket Nishant June 12 (Reuters) - Chime is set to debut on the Nasdaq later on Thursday after raising $864 million in its initial public offering, with investors waiting to...
Chime set for long-awaited market debut after $864 million US IPO
Chime set for long-awaited market debut after $864 million US IPO
Jun 12, 2025
(Reuters) -Chime is set to debut on the Nasdaq later on Thursday after raising $864 million in its initial public offering, with investors waiting to see whether the digital bank will maintain the recent streak of explosive first-day gains for new listings. The hotly anticipated debut is being viewed as a bellwether for other IPO candidates in the fintech industry,...
BRIEF-Biontech Announces Strategic Transaction To Acquire Curevac In Public Exchange Offer
BRIEF-Biontech Announces Strategic Transaction To Acquire Curevac In Public Exchange Offer
Jun 12, 2025
June 12 (Reuters) - BIONTECH SE: * BIONTECH ANNOUNCES STRATEGIC TRANSACTION TO ACQUIRE CUREVAC IN PUBLIC EXCHANGE OFFER * PUBLIC EXCHANGE OFFER FOR ALL SHARES OF CUREVAC WHERE EACH SHARE OF CUREVAC WILL BE EXCHANGED FOR APPROX. $5.46 IN BIONTECH AMERICAN DEPOSITARY SHARES * IMPLIED AGGREGATE EQUITY VALUE FOR CUREVAC OF APPROX. $1.25 BILLION * EXPECTED TO CLOSE IN 2025...
Copyright 2023-2026 - www.financetom.com All Rights Reserved